Novo Nordisk's pipeline, especially the oral GLP-1 and Alzheimer’s trial, offers significant long-term upside. Click here to ...

Wegovy® is indicated for chronic weight management in adults and adolescents (12+) with obesity or overweight and at least ...

In a recent panel conversation, healthcare and industry experts discussed where to find reliable guidance in a sea of ...

A once-weekly injection of Wegovy® has become available in Singapore, marking the latest step in managing obesity as a ...

Over 60 novel drug candidates are in late-stage clinical trials in China, and these will potentially compete directly with US ...

An updated edition of the June 4, 2025 article. The world is in the midst of a historic demographic shift with populations ...

The investigational dual GLP-1 and amylin receptor agonist Amycretin demonstrated significant weight loss—up to 24% with ...

Individualized ocular characteristics should be considered before starting GLP-1 RA therapies for weight loss and diabetes ...

Monthly weight-loss shots on the horizon! Learn about new drugs like MariTide and why Black participation in clinical trials ...

SINGAPORE - An injectable drug used to treat obesity is now available via prescription from any licensed physician in ...

Researchers conducted the REDEFINE 1 and REDEFINE 2 clinical trials to assess the effect of CagriSema on weight loss in obesity with or without type 2 diabetes.

Black adults who underwent a sleeve gastrectomy had a lower total weight loss and higher HbA1c after surgery than white and ...